Protective effects of hydroxyethyl starch (130/0.4) against ischemia reperfusion injury of kidney: Experiment with rats

National Medical Journal of China

Volumn 87, Issue 45, 2007, Pages 3224-3227

  Zhou, Da Chun ^a   Ma, Xiao Xu ^a   Xie, Jun Ran ^a   Luo, Feng ^a   Jin, Mei ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Hetastarch; Intercellular adhesion molecule 1; Kidney; Reperfusion injury

Indexed keywords

CREATININE; HETASTARCH; INTERCELLULAR ADHESION MOLECULE 1; NITROGEN; SODIUM CHLORIDE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTERY CLAMP; ARTICLE; BLOOD SAMPLING; CALCULATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; NEPHRECTOMY; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL ARTERY; RENAL PROTECTION; REPERFUSION INJURY; SCORING SYSTEM; UREA NITROGEN BLOOD LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; HETASTARCH; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; KIDNEY DISEASES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 40449125933     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001,357:911-916.
2. Tian J, Lin X, Guan R, et al. The Effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004,98:768-774.
3. Toback FG. Regeneration after tubular necrosis. Kidney Int, 1992, 41:226-246.
4. Ragaller MJ, Theilen H, Koch T. Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol, 2001, 17: S33-39.
5. Kasper SM, Stromich A, Kampe S, et al. Evaluation of a new hydroxyethyl starch solution (130/0.4) in patients undergoing preoperative autologous blood donation. J Clin Anesth,2001,13: 486-490.
6. Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacyokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/ 0. 4 in mild-to-severe renal impairment. Anesth Analg, 2002, 95:544-551.
7. Rabh H, O'Meara YM, Maderna P, et al. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int, 1997,51:1463-1468.
8. Kelly KJ, Williams WW, Colvin RB. Intercellular adhesion molecule-1 deficient mice are protected against ischemic renal injury. J Clin Invest, 1996,97:1056-1063.
9. Kelly KJ, Williams WW, Colvin RB. Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA,1994,91:812-816.
10. Bear PC. Induction of RANTES, HLA-DR and intercellular adhesion molecule-1 on highly purified distal tubular cells from human kidney. Transplantation,2000,69:2456-2459.
11. Nohe B, Burchard M, Zanke C, et al. Endothelial accumulation of hydroxyethyl starch and functional consequences on leukocyte-endothelial interactions. Eur Surg Res, 2002,34:364-372.
12. Rittoo D, Gosling P, Simms MH, et al. The effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg, 2005,30:520-524.
13. Collis RE, Collins PW, Gutteride CN, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study, Intensive Care Med, 1994,20:37-41.
14. Standl T, Burmeister MA, Schroeder F, et al. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0. 5 or HES 200/0. 5 in volunteer undergoing acute normovolemic hemodilution. Anesth Analg, 2003,96:936-943.
15. Allison KP, Gosling P, Jones S, et al. Randomized trial of hydroxylthyl starch verus gelatin for trauma resuscitation. J Trauma, 1999,47:1114-1121.
16. Maximilian J, Ragaller R, Hermann T, et al. Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol,2001,17: S33-39.